Geneyx

Herzliya, Israel Founded: 2018 • Age: 8 yrs
Provider of a clinical genetics data management platform for hospitals and genetic labs
Annual revenue - Latest available
Total funding $10.0M 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Geneyx

Geneyx is a company based in Herzliya (Israel) founded in 2018. Geneyx has raised $10 million across 1 funding round from investors including Accenture and Capri Ventures. Geneyx has completed 1 acquisition, including Toldot Genetics. Geneyx operates in a competitive market with competitors including Strand Life Sciences, DNAnexus, Genomics, Seven Bridges Genomics and Cellworks, among others.

  • Headquarter Herzliya, Israel
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $10 M (USD)

    in 1 rounds

  • Latest Funding Round
    $10 M (USD), Seed

    Nov 09, 2021

  • Investors
    Accenture

    & 1 more

  • Employee Count
    Not available
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Geneyx

Headcount 10-50
Employee Profiles 10
Board Members and Advisors 4
Employee Profiles
People
David Yizhar
CEO
People
Dvir Dahary
CSO

Unlock access to complete

Funding Insights of Geneyx

Geneyx has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Seed round of $10 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Geneyx

Geneyx has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Accenture and Capri Ventures.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage VC fund for enterprise tech startups
Locked Locked Locked
IT and management consultancy services are provided globally.
Locked Locked Locked
Premium access

Investor details for Geneyx

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Geneyx

Geneyx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Toldot Genetics.

Investments
Premium access

Investment portfolio details for Geneyx

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Provider of genome sequencing tools and genetic tests
Locked Locked 2012 Locked
Premium access

Complete acquisition details for Geneyx

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Geneyx

Premium access

Detailed financials for Geneyx

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Geneyx Comparisons

Geneyx Primary company
Description
Provider of a clinical genetics data management platform for...
Location
Herzliya, Israel
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Geneyx

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Geneyx

Geneyx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, DNAnexus, Genomics, Seven Bridges Genomics and Cellworks, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
Locked Locked Locked
Cloud-based genome informatics and data management are provided.
Locked Locked Locked
Genomic risk assessment and prevention platform is provided.
Locked Locked Locked
Cloud-based platform to analyze, store, and act on genomic data.
Locked Locked Locked
Biosimulation platform developed for therapeutic design in life sciences.
Locked Locked Locked
AI-based omics data analysis solutions are provided to researchers.
Premium access

Detailed competitors of Geneyx

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Geneyx

Premium access

Complete news archive for Geneyx

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Geneyx

Geneyx was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Geneyx is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.

Geneyx is a funded company, having raised a total of $10M across 1 funding round to date.

Provider of a clinical genetics data management platform for hospitals and genetic labs. The company offers an AI-based solution for next-generation sequencing (NGS) data, customizable workflows, rapid phenotype-driven interpretation, and Integrations that can scale the process of FASTQ to clinical reports for hospital and commercial labs.

Geneyx's top competitors include Strand Life Sciences, DNAnexus and Eagle Genomics.

Geneyx has made 1 acquisition, including Toldot Genetics.

Geneyx has 2 investors. Key investors include Accenture, and Capri Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available